A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight

Molecular Genetics and Metabolism

Volumn 96, Issue 1, 2009, Pages 50-51

  Kalkan Ucar, Sema ^a   Coker, Mahmut ^a   Argin, Mehmet ^a   Akman, Sezin ^a   Kara, Sinan ^a   Goksen Simsek, Damla ^a   Darcan, Sukran ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Gaucher type I disease; Insulin resistance; Normal weight

Indexed keywords

ENZYME; FATTY ACID; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME REPLACEMENT; FATTY ACID BLOOD LEVEL; FEMALE; GAUCHER DISEASE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PILOT STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; INSULIN RESISTANCE; MALE; MUTATION; OVERWEIGHT; PILOT PROJECTS;

EID: 57449112969     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.10.001     Document Type: Article

References (8)

1. Langeveld M., Ghauharali K.J., Sauerwein H.P., Ackermans M.T., Groener J.E., Hollak C.E., Aerts J.M., and Serlie M.J. Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. J. Clin. Endocrinol. Metab. 93 (2008) 845-851
2. Langeveld M., de Fost M., Aerts J.M., Sauerwein H.P., and Hollak C.E. Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy. Blood Cells Mol. Dis. 40 (2008) 428-432
3. Di Rocco M., Giona F., Carubbi F., Linari S., Minichilli F., Brady R.O., Mariani G., and Cappellini M.D. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Haematologica 93 (2008) 1211-1218
4. Poll L.W., Koch J.A., Willers R., Aerts H., Scherer A., Häussinger D., Mödder U., and vom Dahl S. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol. 30 (2001) 496-503
5. Stern S.E., Williams K., Ferrannini E., DeFronzo R.A., Bogardus C., and Stern M.P. Identification of individualswith insulin resistance using routine clinical measurements. Diabetes 54 (2005) 333-339
6. Ergun-Longmire B., and Maclaren N.K. Insulin resistance syndrome in childhood and beyond. In: Lifshits F. (Ed). Pediatric Endocrinology. 5th ed. (2007), springer, berlin 212-249
7. Pocovi .M., Cenarro A., and Civeira F. Beta-glucocerebroside gene locus as a link for Gaucher's disease and familial hypo-alphalipoproteinemia. Lancet 351 (1998) 1919-1923
8. Ghauharali-van der Vlugt K., Langeveld M., Poppema A., Kuiper S., Hollak C.E., Aerts J.M., and Groener J.E. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clin. Chim. Acta 389 (2008) 109-113